| Drugs with this side effect
			
	        	5-ASA: very rare, postmarketing, 0% - 7% 
				5-FU
				5-aza-2'-deoxycytidine: 1.23% - 8.43% 
				5-azacytidine: common 
				6-mercaptopurine
				A77 1726: 13% - 13.1% 
				Azarga
				BCNU: 1-10% - 10% 
				CAS 76095-16-4
				CAS 76420-72-9: postmarketing 
				CGP 19835A: common 
				D-penicillamine
				DFMO: 1.3% - 2.5% 
				Estrofem
				FAMP: 0% - 3% 
				FTY720: common, 3.53% - 4% 
				FdUrd
				Goserelin: 1-10% 
				Implanon: postmarketing 
				K779: 8% - 38% 
				Kaluril
				L-Dmp: infrequent 
				LMWH: postmarketing 
				Leuprorelin
				LiOH
				Lisinopril: postmarketing, rare 
				Lovaza
				Metrodin
				NTBC
				Nafarelin
				NuvaRing
				Octreotide: common, 1% - 3.51% 
				Oestrogen: common 
				Promacta
				SOM230: 12.2% - 12.5% 
				SU5416
				Signifor: 12.2% - 12.5% 
				Stalevo 50
				TPGS
				Triptorelin
				Trisequens
				UDCA: postmarketing, 5.28% - 5.3% 
				VACV: postmarketing 
				Zyprexa Relprevv: very rare 
				abacavir
				abacavir-lamivudine: postmarketing 
				acamprosate: infrequent 
				acenocoumarol
				acetohydroxamic acid
				acitretin: postmarketing, 7-75% 
				actinomycin D
				acyclovir: postmarketing, uncommon 
				afatinib: 0% - 13% 
				alendronate: postmarketing 
				allopurinol
				alosetron: rare 
				amantadine: very rare 
				amiloride
				amiodarone
				amitriptyline
				amlodipine
				amlodipine besylate
				amoxapine: postmarketing 
				amphetamine
				amphotericin B
				amsacrine
				anagrelide: 1-5% 
				anastrozole
				anthracycline: 0% - 36% 
				aprepitant: 11.9% - 24% 
				aripiprazole
				atazanavir: postmarketing, uncommon 
				atenolol
				atorvastatin
				auranofin
				axitinib: 0% - 32% 
				azathioprine: rare 
				baclofen: uncommon 
				balsalazide: postmarketing 
				benazepril
				benazeprilat
				betaine: postmarketing, uncommon 
				betaxolol: postmarketing 
				bexarotene: 3.57% - 11.3% 
				bezafibrate
				bicalutamide: 1-5% - 4% 
				bisoprolol: very rare, postmarketing 
				bleomycin hydrochloride
				boceprevir: very common, 16% - 27% 
				brinzolamide: postmarketing 
				bromocriptine: postmarketing, uncommon 
				budesonide
				bupropion: postmarketing, infrequent 
				buspirone: infrequent 
				busulfan
				cabazitaxel: 0% 
				cabergoline: postmarketing 
				cabozantinib: 0% - 16% 
				capecitabine: 1% - 42% 
				captopril
				carbamazepine: very rare, rare 
				carbidopa
				carbimazole
				carboplatin: 2% - 3% 
				carvedilol: postmarketing 
				cefpodoxime
				celecoxib
				cerivastatin
				cetirizine
				cevimeline
				chlorambucil
				chloroquine
				choline theophyllinate
				ciclopirox: postmarketing, rare 
				cidofovir: postmarketing, very common, 27% 
				cilazapril: postmarketing 
				ciprofloxacin
				cisplatin
				citalopram: postmarketing, infrequent, uncommon 
				cladribine
				clindamycin phosphate
				clobetasol: postmarketing 
				clobetasol propionate
				clofarabine: common 
				clomiphene citrate: 0.3% 
				clomipramine: very rare, infrequent 
				clonazepam
				clonidine
				colchicine: postmarketing 
				copolymer 1
				cyclobenzaprine: postmarketing 
				cyclophosphamide
				cyproterone acetate
				cytarabine
				dabrafenib: very common, 0% - 22% 
				dacarbazine: 1-10% 
				dalteparin: postmarketing 
				danazol
				darunavir
				dasatinib
				deferasirox: postmarketing 
				degarelix
				delamanid
				delavirdine
				deprenyl: infrequent, 0% 
				desipramine
				desogestrel
				desvenlafaxine
				dexamethasone
				dexrazoxane: 94% - 100% 
				diclofenac: very rare, 0% - 2% 
				didanosine: postmarketing 
				diethylpropion
				diltiazem: postmarketing 
				dipyridamole
				docetaxel: very rare, 0% - 98% 
				donepezil: infrequent 
				dorzolamide
				doxazosin: postmarketing 
				doxepin
				doxorubicin: common, very common, 6.7% - 95.5% 
				duloxetine: infrequent 
				efavirenz
				eletriptan: rare 
				eltrombopag
				entecavir: postmarketing, uncommon 
				eribulin: 10% - 45% 
				erlotinib
				eslicarbazepine acetate
				esomeprazole magnesium: postmarketing 
				estradiol: postmarketing, uncommon 
				estramustine: 1% 
				estramustine phosphate
				etidronate: postmarketing 
				etodolac: postmarketing 
				etoposide: 33% - 8-66% 
				etoposide phosphate
				etoricoxib
				everolimus: common 
				exemestane: common, 2-5% - 15.1% 
				exenatide: postmarketing, rare, 0% - 2.07% 
				ezetimibe
				famotidine
				febuxostat
				felbamate
				fenofibrate: rare 
				fenoprofen: postmarketing 
				fentanyl
				flecainide: postmarketing 
				fluconazole: postmarketing, rare 
				fludarabine: 0% - 3% 
				fluocinolone acetonide
				fluoxetine: infrequent, uncommon 
				fluoxymesterone
				flurbiprofen
				fluvastatin: postmarketing 
				fluvoxamine: rare, infrequent 
				gabapentin: postmarketing, infrequent 
				ganciclovir
				gefitinib: common, 1-10% 
				gemcitabine: common, 0% - 92% 
				gemfibrozil
				gentamicin
				glibenclamide
				gold sodium thiomalate
				granisetron: 3% 
				guanfacine: postmarketing 
				haloperidol
				heparin: postmarketing 
				hepatitis B vaccines
				hydrochlorothiazide
				hydroxybutyrate
				hydroxychloroquine
				hydroxyurea: uncommon, 1-5% 
				ibandronate
				ibuprofen
				idarubicin: 72% - 77% 
				ifosfamide: 1-83% - 83% 
				imatinib: common, 0% - 22.3% 
				imipramine: very rare 
				imiquimod: 0% - 1.4% 
				indinavir: postmarketing 
				indomethacin
				insulin detemir
				irinotecan: 16.8% - 72% 
				itraconazole: postmarketing 
				ixabepilone: 0% - 48% 
				ketoconazole: postmarketing 
				ketoprofen
				ketorolac
				ketorolac tromethamine
				lamivudine: postmarketing, common 
				lamotrigine: infrequent 
				lanreotide
				lansoprazole
				lapatinib: very common, 0% - 7% 
				lasofoxifene: uncommon 
				leflunomide: postmarketing, common, 1% - 17% 
				lenalidomide: common 
				lercanidipine
				letrozole: common, 2.09% - 3.43% 
				leucovorin: 5% - 43% 
				leuprorelin acetate: 1.7% - 42% 
				levetiracetam: postmarketing 
				levobunolol
				levodopa/carbidopa
				levonorgestrel
				lindane: postmarketing 
				lithium
				lithium carbonate
				lomustine
				loratadine: postmarketing 
				lorazepam
				losartan
				lovastatin: postmarketing 
				loxapine
				maprotiline
				maraviroc
				meclofenamate: postmarketing 
				medroxyprogesterone: 1.1% 
				medroxyprogesterone acetate
				mefenamic acid
				mefloquine: postmarketing 
				megestrol
				megestrol acetate
				meloxicam
				melphalan: common, very common 
				memantine: infrequent 
				mephenytoin
				mesna: 10.1% - 13% 
				methimazole
				methotrexate: 1-10% 
				methylphenidate: postmarketing, common 
				methyltestosterone
				methysergide
				metoprolol: rare 
				metyrapone
				mexiletine
				minocycline
				mirtazapine: postmarketing, infrequent 
				misoprostol: postmarketing 
				mitomycin C
				mitoxantrone: 0% - 61% 
				moexiprilat
				mycophenolate mofetil
				mycophenolic acid: postmarketing 
				nabumetone: postmarketing, 0.9% 
				nadolol
				naltrexone
				nandrolone
				naproxen: postmarketing 
				naratriptan: rare 
				nefazodone: infrequent 
				niacin
				nifedipine
				nilotinib: common, 0% - 14% 
				nisoldipine
				nitrofurantoin
				nitrogen mustard
				norethisterone
				nortriptyline
				ofloxacin
				olanzapine: very rare, postmarketing, infrequent 
				olmesartan: postmarketing 
				olmesartan medoxomil
				olsalazine
				omeprazole: postmarketing, rare, uncommon 
				orlistat
				oxaliplatin: common, very common, 0% - 44.1% 
				oxaprozin
				oxcarbazepine: common 
				oxymetholone
				paclitaxel: very common, 87% - 94% 
				paliperidone: postmarketing 
				palonosetron
				pamidronate
				pantoprazole: postmarketing 
				paricalcitol
				paroxetine: infrequent, uncommon 
				pazopanib: 0% - 12% 
				pemetrexed: 6% - 42% 
				pentosan polysulfate: 4% 
				pentostatin
				pergolide: infrequent 
				perindopril erbumine
				pilocarpine
				pirbuterol
				piroxicam
				pixantrone
				ponatinib
				posaconazole
				pramipexole
				pravastatin
				prazosin
				prednisone
				pregabalin: infrequent 
				probenecid
				procarbazine
				progesterone: postmarketing 
				propafenone: postmarketing 
				propranolol: postmarketing 
				propylthiouracil
				protriptyline
				pyridostigmine
				quinapril
				quinaprilat
				rabeprazole
				raltegravir
				raltitrexed: 4-5% 
				ramipril
				ranitidine
				rasagiline
				regorafenib
				repaglinide
				retigabine
				retinoic acid: postmarketing, 13% - 14% 
				ribavirin: very common, 17% - 36% 
				rifapentine
				riluzole: 0% - 1.2% 
				risperidone: postmarketing, infrequent 
				rivastigmine: infrequent 
				rofecoxib
				ropinirole: infrequent, frequent 
				salmon calcitonin acetate: postmarketing 
				samarium
				saquinavir: common 
				selenium
				selenium sulfide
				sertraline: postmarketing, infrequent, uncommon, frequent 
				sibutramine
				sildenafil
				simvastatin: postmarketing 
				sitaxsentan
				sofosbuvir: common 
				sorafenib: postmarketing, 0% - 27% 
				sotalol: postmarketing 
				sparfloxacin
				spinosad
				spironolactone
				strontium ranelate: postmarketing 
				sulfasalazine
				sulindac
				sunitinib
				tacrolimus: common, 0% - 1% 
				tamoxifen: 5% - 5.2% 
				tegaserod: postmarketing 
				temazepam
				temozolomide: common, very common, 0% - 69.1% 
				teniposide: 9% 
				terbinafine: postmarketing 
				testolactone
				testosterone: postmarketing, 0% - 1% 
				testosterone enanthate: postmarketing 
				testosterone propionate
				testosterone undecanoate
				thalidomide
				theophylline
				thiazide
				thiotepa: 1-10% 
				thyroxine
				tiagabine: frequent 
				timolol
				tizanidine: infrequent 
				tolcapone: 1% 
				topiramate: postmarketing, rare, 0% - 6.3% 
				topotecan: very common, 0% - 54% 
				toremifene
				trabectedin
				trandolapril: postmarketing 
				trandolaprilat: postmarketing 
				tranylcypromine
				trazodone: postmarketing 
				trimethadione
				trimipramine
				v 1784: postmarketing, 0% - 4% 
				valdecoxib
				valganciclovir
				valproate: 2.4% - 24% 
				valsartan: postmarketing 
				vandetanib: 8% 
				vemurafenib: postmarketing, 0% - 45% 
				venlafaxine: postmarketing, infrequent, uncommon 
				verapamil: postmarketing 
				vinblastine
				vincristine
				vinflunine
				vinorelbine: 0% - 30% 
				vismodegib: 63.8% - 65.2% 
				voriconazole: common 
				vorinostat
				warfarin
				zalcitabine
				zaleplon: infrequent 
				zidovudine/lamivudine: postmarketing 
				ziprasidone: rare, infrequent 
				zoledronic acid
				zonisamide: infrequent 
				zopiclone: infrequent 
				 | Drugs with this indication |